Hydantoin compounds
US7666875B2 · kind B2 · utility
9Cited by
0References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 26, 2006 |
| Grant date | Feb 23, 2010 |
| Priority date | — |
| Expiry date | May 26, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of hydantoin compounds useful for treating or preventing autoimmune disorders. The present invention also provides compositions and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.